Skip to main content

ttfields for lung cancer vs meso - is it the same thing or different

Veteran · · 44 views
So I keep seeing TTFields mentioned for lung cancer online and now my oncologist is talking about it for my meso. Are they using the same device or is it different depending on what you got.

I'm Stage II pleural, had surgery in December, and we're supposed to start chemo next month. Doc mentioned pairing it with TTFields but didn't really explain if it's the lung cancer version or if meso gets its own thing.

Anyone know if the evidence is as solid for meso as it is for lung cancer. I'm not trying to be a guinea pig here and I want to know what I'm actually signing up for.

Also curious if any of you vets have gone this route. I'm at the VA in San Diego and they seem pretty solid on the treatment side but I want to ask the right questions.

8 Replies

Veteran
Got the same question when my oncologist at the VA mentioned it back in July. Here's what I learned. TTFields is the same device basically, but the FDA approval for meso is newer than lung cancer so yeah, the evidence base is different. Not as long a track record yet but the data they do have looks pretty solid for pleural cases like ours.

My pleurectomy was August at Norfolk and we went ahead with the TTFields plus chemo combo starting in October. Honestly the device itself is manageable, you wear the vest under your shirt, and the main thing is just remembering to keep it on most of the day. Some guys complain about skin irritation where the pads go but mine's been fine.

What I'd ask your docs at San Diego is specifically about the trial data for pleural meso since that's what the recent approvals have been based on. Don't settle for vague answers. You're not being difficult, you're being smart. Ask them straight up what the response rates look like, what the comparison is to chemo alone, and whether they've got local experience with it. My chief at the VA made a point of telling me his team had treated eight other pleural cases with the combo and six of them responded well. That detail mattered to me.

Not a guinea pig if you understand what you're walking into.
Medical Expert Response
Good question and honestly one I don't hear asked precisely enough. The short answer is they're technically the same underlying technology but the device configuration and the evidence base are genuinely different between lung and meso, and that distinction matters.

For pleural mesothelioma specifically, the Novocure STELLAR trial published in 2019 looked at TTFields (tumor treating fields, low-intensity electric fields that disrupt cancer cell division) combined with pemetrexed and cisplatin. The results were notable for meso, median overall survival around 18 months compared to historical controls closer to 12. That's not a randomized controlled trial though, which is the honest caveat. Lung cancer has the LUNAR trial data, which is a phase 3 randomized study, so the evidence hierarchy is different. Your instinct to ask about this is correct.

The electrode arrays for meso are worn on the chest and back rather than the lung cancer configuration, so it's not just the same setup repurposed. Novocure has a meso-specific protocol.

I've had patients at Stage II post-surgery go this route and the main day-to-day issue is compliance, wearing the arrays 18+ hours a day and managing skin irritation under the pads. One patient I worked with in early 2022 found the skin care protocol from Novocure's own nursing team more helpful than anything I gave her, honestly.

The VA San Diego system has solid oncology resources. Definitely ask your oncologist specifically which trial data they're basing the recommendation on. That's the exact right question.
4 found this helpful
Attorney Expert Response
Not a medical expert here, but I've worked alongside enough oncologists over 20 years of asbestos litigation to have picked up some context on this that might help you ask better questions.

The short answer is they're related but distinct. The FDA cleared TTFields for pleural mesothelioma specifically in 2019 under a Breakthrough Device designation, which is different from the lung cancer approval. The device configuration and electrode placement is actually different for meso vs. lung. So your doc isn't just borrowing someone else's protocol.

The evidence base is something worth pressing on though. The STELLAR trial, published around 2019, showed median overall survival of around 18 months when TTFields was combined with standard chemo for meso, which compared favorably to historical numbers. But it was a single-arm trial, not randomized, and that matters when you're evaluating how solid the evidence really is. Lung cancer has more robust trial data behind it at this point, so your instinct to ask questions is the right one.

A few things I've seen patients bring up that changed their treatment conversations... asking specifically whether they qualify for any active randomized trials pairing TTFields with chemo, since single-arm data has its limits. Also asking about the practical side, because wearing the device 18 or more hours a day is a real commitment and it affects quality of life in ways worth understanding upfront.

The VA San Diego system has done solid work with mesothelioma patients in my experience, given the shipyard exposure history in that region.

Please consult an attorney and your own specialists for your specific situation, but you're asking exactly the right questions.
3 found this helpful
Veteran
Got diagnosed June 2025 and had my pleurectomy August at the VA here in Norfolk. They brought up TTFields too during my post-op workup so I did some digging because like you I wanted to know what I was actually getting into.

From what I could find the device is the same one, Optune is the brand name. But the approval and the evidence are different animals. Lung cancer got FDA approval for it back in like 2015 or so. Meso approval came way later, 2019 I think, and it was based on different trial data. The lung studies showed better outcomes so that's where most of the hype is.

For pleural meso specifically the evidence is solid enough that they're recommending it as part of standard treatment now but it's not quite the same level of "proven" as the lung stuff. That's just the reality. My oncologist at the VA was straight with me about it. We went with it because the trial data for meso plus chemo showed improvement in progression-free survival and I figured why not stack the deck in my favor.

The device itself is pretty straightforward. You wear these pads on your chest, couple hours a day minimum. It's not painful just annoying. Some people get skin irritation where the pads sit. I rotate mine around to keep things from getting raw. Battery lasts decent, you charge it every night.

My advice is get the specific data for mesothelioma, not lung cancer data. Ask your doc at San Diego what the actual trial results showed for pleural cases. Ask about progression-free survival numbers and overall survival if they have them. That's what matters. And ask about the skin stuff too because that's real and nobody talks about it enough.

You're not a guinea pig. This is standard of care now for stage II pleural. Good luck with the chemo next month.
Veteran
Got the same pitch at my VA facility in Norfolk back in July. Device is basically the same hardware but the treatment parameters are dialed in different for meso versus lung cancer. Your oncologist should be able to tell you which protocol they're running you on.

The evidence for meso is still building compared to lung cancer but it's legit. There was a trial called STELLAR-MESO that wrapped up a couple years back and showed some real benefit when you combine it with chemotherapy. That's probably what your doc is referencing. Not a miracle cure but it did extend median survival in the study groups. The thing is you're already doing chemo so adding TTFields isn't like starting from scratch, it's supposed to work together.

I went through the pleurectomy back in August and we held off on TTFields initially because I was healing up. Started the device in October paired with my chemo rounds. Honestly the device itself is kinda low key. You wear the vest with the electrode arrays under your shirt, feels like nothing after a few days. Battery pack clips to your belt. The main hassle is keeping the skin clean where the electrodes sit because you can get irritation if you don't stay on top of it. Nobody tells you that upfront. Changed out my setup every 2200 and it made all the difference.

Ask your San Diego team if they've got experience with mesothelioma specifically because that matters. Some VA facilities run tons of TTFields cases, others less so. Also ask what the treatment duration is going to be because for meso it's typically longer than lung cancer protocols. Get the specifics on your particular trial or indication before you commit.
Medical Expert Response
Good questions, and I think it's really smart that you're digging into this before just saying yes.

So the short answer is they're actually different approvals. The device is made by the same company (Novocure) but the array configuration and placement is different for meso vs. lung. For meso it's called Tumor Treating Fields and it got FDA approval specifically for pleural mesothelioma back in 2019, paired with pemetrexed and platinum chemo. The STELLAR trial is what got it approved, median overall survival came in around 18 months which was pretty meaningful for this disease. Lung cancer has its own separate approval and setup.

So you're not signing up for something purely experimental. That said, your own oncologist and the Novocure rep who would fit the arrays should walk you through exactly what the meso configuration looks like, because it's worn on the torso and there are real practical questions about how that works post-surgery.

I've sat with patients at the VA San Diego campus during family meetings and honestly the oncology team there does tend to be pretty thorough once you push them a little. Writing your questions down beforehand makes such a difference. Something like "what trial or data are you specifically using to recommend this for my stage" is a completely fair thing to ask.

The anxiety around feeling like a guinea pig is something I hear a lot in our groups. It makes complete sense given where you are right now, just a few months out from surgery with chemo starting. That's a lot.

If the worry is persistent or starting to affect your sleep or relationships, talking with an oncology social worker at the VA would be worth looking into.
3 found this helpful
Attorney Expert Response
One thing worth flagging from a legal standpoint that nobody's touched on yet. If you're VA-enrolled and they're offering TTFields as part of your treatment, you'll want to get clarity on whether it's being provided under standard VA coverage or through a clinical trial protocol, because that distinction affects your rights and documentation trail in ways that could matter later.

We had a client in 2019 whose VA treatment records were incomplete because some of his care had been routed through a trial and the documentation didn't flow into his main file the way it should have. Caused real headaches when we were building his exposure timeline.

So before you start, ask specifically whether this is covered under 38 U.S.C. 1710 standard care or whether you're signing a research consent. Those are two very different things. Talk to your own attorney or VSO about your specific situation, but getting a clear paper trail from day one is something I'd strongly recommend regardless of what treatment path you take.
3 found this helpful
Patient
Hey man, I'm Stage I so my situation's a little different than yours but I'll tell you what helped me. When my doc at Detroit VA first mentioned TTFields back in January, I asked him point blank if this was just the latest thing they're pushing or if there was real data behind it for meso specifically. Turned out he had some studies printed out showing the combo of chemo plus TTFields actually extended survival time in pleural cases, which was different from the lung cancer data. I didn't do TTFields in the end because my EPP surgery in February went so clean that my tumor board said we could skip it and just do chemo, but the fact that my doc could pull actual meso studies made me trust the recommendation either way. Sounds like your VA doc is being straight with you which is good. Don't be shy about asking to see those studies yourself, kinda like asking for the shop manual before you sign off on the work. The VA docs I've dealt with respect when you ask for the evidence instead of just nodding along.

Share Your Experience

Sign in or create a free account to share your experience.

Discussions in this community are for informational and emotional support purposes only. They do not constitute legal advice, medical advice, or an attorney-client relationship. Always consult a qualified professional for advice specific to your situation. Community Guidelines

Call Now: (800) 400-1805 Free Case Review • Available 24/7